mTOR signaling in growth control and disease - Wikidata - awgldk - TriplyDB

mTOR signaling in growth control and disease

mTOR signaling in growth control and disease

http://www.wikidata.org/entity/Q24634174

about

Akt and mTOR in B Cell Activation and Differentiation Genetic characterization of the Drosophila birt-hogg-dubé syndrome gene Autophagy in idiopathic pulmonary fibrosis TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1 A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1 5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia SCFFbxo9 and CK2 direct the cellular response to growth factor withdrawal via Tel2/Tti1 degradation and promote survival in multiple myeloma SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1 A positive role of mammalian Tip41-like protein, TIPRL, in the amino-acid dependent mTORC1-signaling pathway through interaction with PP2A Metabolism. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1 mTOR regulates lysosomal ATP-sensitive two-pore Na(+) channels to adapt to metabolic state DNA-dependent protein kinase catalytic subunit (DNA-PKcs)-SIN1 association mediates ultraviolet B (UVB)-induced Akt Ser-473 phosphorylation and skin cell survival mTORC2 phosphorylates protein kinase Cζ to regulate its stability and activity Control of Paip1-eukayrotic translation initiation factor 3 interaction by amino acids through S6 kinase Proteomic analysis of cap-dependent translation identifies LARP1 as a key regulator of 5'TOP mRNA translation Inhibition of Akt/mTOR signaling by the dietary flavonoid fisetin Metabolism of kidney cancer: from the lab to clinical practice The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction Lessons from C. elegans: signaling pathways for longevity mTOR is a key modulator of ageing and age-related disease Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells The life cycle of the 26S proteasome: from birth, through regulation and function, and onto its death Autophagy in Chronic Kidney Diseases Diabetes mellitus and metformin in hepatocellular carcinoma Conserved regulators of Rag GTPases orchestrate amino acid-dependent TORC1 signaling The Mucosal Immune System and Its Regulation by Autophagy Cap-Independent Translational Control of Carcinogenesis Fundamentals of cancer metabolism Immune Dysfunction as a Cause and Consequence of Malnutrition Interactions between Autophagy and Inhibitory Cytokines Role of mTOR Inhibitors in Kidney Disease Advances in Autophagy Regulatory Mechanisms Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects The crucial impact of lysosomes in aging and longevity Meeting the meat: delineating the molecular machinery of muscle development The mTOR pathway in obesity driven gastrointestinal cancers: Potential targets and clinical trials Immunosuppressive potency of mechanistic target of rapamycin inhibitors in solid-organ transplantation Radioresistance of Brain Tumors Resveratrol Inhibition of Cellular Respiration: New Paradigm for an Old Mechanism Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play

P2860

Q21131224-91A8F067-BDCA-4080-B356-A94EC425AA12 Q21133019-AA99CF7D-786F-4DA4-BA43-3459122E417E Q21134133-C30E16A3-8A3E-4A70-842A-123A74761969 Q24293153-48721498-FD52-4682-8B9F-4DB3C64D8DD6 Q24294219-D13CF642-AF57-466F-8506-C1E659DB0939 Q24299992-D44A7ED0-B907-4817-B4C8-837E6D6FC9DE Q24306820-8E9D64FC-18A5-4860-93BA-0E5A7A36CA78 Q24312292-9FF8CFE9-7A58-4A7C-BE23-994F3B4430DD Q24312822-D91F762E-252C-4BE6-9CC8-6110405B5C41 Q24313010-D106278D-24F9-4716-953F-9FC1B6773E98 Q24315101-D74B3B48-3ACF-43EF-9C55-AB4F9498BB66 Q24316008-59398FCA-CAA6-49CB-8BC4-58DB755B17B9 Q24316926-BC9B49EF-8AFD-46C8-97E5-44711ECFCFAD Q24317685-97961300-B0E9-4A89-9585-D8AA8D666288 Q24337405-87B5430B-6E95-4FD9-8662-BEA3BBB75E8F Q24568189-892351A0-FE4F-4412-8062-B787F474B8BD Q24600512-15F79405-D5D0-4B0E-9980-046C2C079CA9 Q24603159-2F866EC5-DE27-4FEC-AB09-5D8F0416E251 Q24609529-3910CA66-C8F6-4B32-A794-C60E5CD2866A Q24610741-8455F62D-AD93-4560-8F4E-9422B8FCE248 Q24626339-5784A470-7856-4455-B76F-F074401803A0 Q26738549-C06A8BA6-6A38-43FD-9F39-8D5DF1DFB788 Q26740427-0AC96C84-3273-4C5C-9D73-C7FEA745D55D Q26741205-75C38ECA-C16B-45C8-9C70-5572B44F2162 Q26741367-FF23B67F-4A1B-4BD0-8E81-B8C6CD206049 Q26742170-D3160619-6E0E-4EFD-8448-13638684A1FE Q26744030-23214227-05CD-44DE-8921-997F1F4077A9 Q26744062-FBFFF8C7-1905-4FB6-8B9D-1FB298B2DA8C Q26745474-FBEE8072-9BD2-4B44-9595-EE4421D1C45F Q26745577-7DC305F1-E9C5-4708-899E-395558F9A9A7 Q26747506-D737F3C6-714A-445E-A82C-6727D0850734 Q26748934-47C675BB-2576-4CB8-971C-DC15CE40D96A Q26749011-0AE92B35-8BEA-48D0-8A99-824805249E9C Q26749118-11AAF115-CB77-4BEB-A246-1D7C167B56EC Q26750626-D46B9CA3-645E-42B4-BD41-9DA2E53FE86A Q26751155-11BA8A12-0853-458B-B95A-60E46BB4480D Q26751433-75B513A8-838D-49D0-BE81-6230371F5816 Q26752579-0F280B53-C051-49FC-861D-6B59EF88614B Q26753034-5573528F-F87C-42D6-AFAA-9E5D485AA158 Q26764911-CD9E0E17-B12F-4EA5-B23E-B796032116A4

P2860

mTOR signaling in growth control and disease

http://www.wikidata.org/entity/Q24634174

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

mTOR signaling in growth control and disease

@ast

mTOR signaling in growth control and disease

@en

mTOR signaling in growth control and disease

@nl

type

label

mTOR signaling in growth control and disease

@ast

mTOR signaling in growth control and disease

@en

mTOR signaling in growth control and disease

@nl

prefLabel

mTOR signaling in growth control and disease

@ast

mTOR signaling in growth control and disease

@en

mTOR signaling in growth control and disease

@nl

P1433

Q24634174-C309B6FA-A10B-4314-B475-2024892DC28E

P1476

Q24634174-D304B280-CB8C-42FD-8B92-B35A2215DCB9

P2093

Q24634174-62D08877-12D9-4EA1-8B29-73071E5B2A4F

Q24634174-ECE202E9-5E85-42E8-A345-E8F0EA3066B4

P2860

Q24634174-02A1AE13-F220-46F1-8D42-B2BDFA2963C7

Q24634174-07345783-6F6E-4050-A5C9-9D587B1C5543

Q24634174-0890E81F-BB18-4DB2-A65E-12A344464813

Q24634174-0920169B-B1E7-4BFC-A253-7040A4585FD7

Q24634174-09D06393-147C-4DC8-93E8-9E2CE2F3C52E

Q24634174-0CAD88FA-CA4D-454C-B5E9-A57DD25FFB5E

Q24634174-0D745893-18F9-4AF9-A90B-EB08CE6B7272

Q24634174-116A3D7C-6A9C-4514-9DD6-A1B01D9525C9

Q24634174-121DD8D4-5E72-4A4B-94CC-A0C85AEB0371

Q24634174-13598DDB-5230-459C-A954-BE11C6D9A8B7

P304

Q24634174-D279B305-F556-4480-8F69-C78360F02E55

P31

Q24634174-9243CE44-7A69-4D95-AA02-9912E5E3BCD0

P3181

Q24634174-D595E803-DFBF-4F58-920E-BF251CB74323

P356

Q24634174-A78D04E9-EB92-4909-AA76-A402578BD298

P407

Q24634174-6E3E3392-7B42-4823-8A98-B3E79561EC28

P433

Q24634174-780C64E8-A3DD-4AFC-A341-ED29A75A0828

P478

Q24634174-B593703D-8296-4471-A65E-1942E98F7343

P577

Q24634174-9C7D78E8-C57D-4465-8EEF-41CC5C2F6175

P5875

Q24634174-9614F69B-76A7-4F0A-8715-A0FC7F6F8DD4

P698

Q24634174-2737B590-06CE-4344-B649-8C0753388637

P932

Q24634174-DCEB0276-4038-465B-A669-9C71C73F0938

P3181

P356

J.CELL.2012.03.017

P1433

P1476

mTOR signaling in growth control and disease

@en

P2093

David M Sabatini

http://www.w3.org/2001/XMLSchema#string

Mathieu Laplante

http://www.w3.org/2001/XMLSchema#string

P2860

Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2

Activation of mTORC2 by association with the ribosome

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton

PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase

mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery

Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action

Requirement of the mTOR kinase for the regulation of Maf1 phosphorylation and control of RNA polymerase III-dependent transcription in cancer cells

Identification of Protor as a novel Rictor-binding component of mTOR complex-2

Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

P304

274-93

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

197646

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.CELL.2012.03.017

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

149

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224034628

http://www.w3.org/2001/XMLSchema#string

P698

22500797

http://www.w3.org/2001/XMLSchema#string

P932

3331679

http://www.w3.org/2001/XMLSchema#string